In silico investigations of patient samples revealed an inverse correlation between recurrence-free survival and cyclin-dependent kinase 8 (CDK8) levels in various breast cancer types, however, a correlation separately for TNBC patients has not yet been reported [4–6]. This evidence concerns the gene CDK8 and breast carcinoma.